Page last updated: 2024-09-04

nps-568 and ARPKD

nps-568 has been researched along with ARPKD in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batlle, D; Harris, PC; Somlo, S; Torres, VE; Wang, X1
Bacallao, RL; Chen, NX; Chen, X; Eggleston-Gulyas, T; Gattone, VH; Herbert, BS; Hoffmeyer, WD; Moe, SM1

Other Studies

2 other study(ies) available for nps-568 and ARPKD

ArticleYear
Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:2

    Topics: Aniline Compounds; Animals; Aquaporin 2; Calcium; Cyclic AMP; Disease Models, Animal; Female; Humans; Kidney; Male; Mice; Mice, Knockout; Mice, Mutant Strains; Phenethylamines; Polycystic Kidney, Autosomal Dominant; Polycystic Kidney, Autosomal Recessive; Propylamines; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rats; Rats, Mutant Strains; Receptors, Calcium-Sensing; Receptors, Vasopressin; RNA, Messenger

2009
Calcimimetics inhibit renal pathology in rodent nephronophthisis.
    Kidney international, 2011, Volume: 80, Issue:6

    Topics: Aniline Compounds; Animals; Calcimimetic Agents; Cell Line; Cell Proliferation; Cyclic AMP; Disease Models, Animal; Female; Humans; Kidney; Kidney Diseases, Cystic; Kinesins; Male; Mice; Mice, Mutant Strains; Mutation, Missense; Phenethylamines; Polycystic Kidney, Autosomal Recessive; Propylamines; Receptors, Calcium-Sensing

2011